These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 17122935)
1. Liver transplantation in transthyretin amyloidoses. When the neurological benefit outweighs the risk. Mascalchi M; Salvi F Neurol Sci; 2006 Nov; 27(5):297-8. PubMed ID: 17122935 [No Abstract] [Full Text] [Related]
11. Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates. Niemczyk R; Brydak-Godowska J; Kecik D; Wagner T; Lewandowski P; Kecik M; Zygier D; Ołdakowska-Jedynak U Transplant Proc; 2009 Oct; 41(8):3085-7. PubMed ID: 19857683 [TBL] [Abstract][Full Text] [Related]
12. A homozygote case of familial amyloid polyneuropathy amyloidgenic transthyretin Val30Met in a non-endemic area. Kumabe Y; Miura A; Yamashita T; Oshima T; Misumi Y; Ueda M; Obayashi K; Horibata Y; Jono H; Ando Y; Uchino M Amyloid; 2011 Jun; 18 Suppl 1():169-70. PubMed ID: 21838475 [No Abstract] [Full Text] [Related]
13. Domino liver transplantation: risks and benefits. Ericzon BG; Larsson M; Wilczek HE Transplant Proc; 2008 May; 40(4):1130-1. PubMed ID: 18555132 [TBL] [Abstract][Full Text] [Related]
14. Inability of mutant transthyretin V30M to cross the blood-eye barrier. Beirão JM; Moreira LV; Lacerda PC; Vitorino RP; Beirão IB; Torres PA; Costa PP Transplantation; 2012 Oct; 94(8):e54-6. PubMed ID: 23080516 [No Abstract] [Full Text] [Related]
16. [Amyloid polyneuropathies--biochemical and genetic aspects]. Delpech M; Valleix S Bull Acad Natl Med; 2012 Oct; 196(7):1309-18; discussion 1318-20. PubMed ID: 23815016 [TBL] [Abstract][Full Text] [Related]
17. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report. Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280 [No Abstract] [Full Text] [Related]
18. Impact of aging on the progression of neuropathy after liver transplantation in transthyretin Val30Met amyloidosis. Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Nakamura T; Watanabe H; Kamei H; Kiuchi T; Sobue G Muscle Nerve; 2012 Dec; 46(6):964-70. PubMed ID: 23225390 [TBL] [Abstract][Full Text] [Related]
19. Presence of autoantibody against ATTR Val30 Met after sequential liver transplantation. Suhr OB; Lundgren E Transplantation; 2002 Mar; 73(5):674-5. PubMed ID: 11907408 [No Abstract] [Full Text] [Related]
20. Development of late amyloid cardiomyopathy following liver transplantation for hereditary Val30Met transthyretin amyloidosis. Gondi KT; Nazir S; Grande R; Hummel SL Amyloid; 2021 Sep; 28(3):215-216. PubMed ID: 33818235 [No Abstract] [Full Text] [Related] [Next] [New Search]